PRESTO Inclusion/Exclusion Criteria The PRESTO model was derived on subjects that did not have any of the following:
- Small Duct PSC
- Another concurrent liver disease including overlap with Autoimmune Hepatitis
- MELD score greater than 14 at baseline
- Prior Liver Transplantation
- Presence of Portal Hypertension (varices, ascites, encephalopathy, splenomegaly, or platelets less than 150 x 10^9/L) at baseline
- Subjects less than 18 years of age
If a person has any of the above, then the calculator may not be valid since PRESTO was not tested under these baseline conditions.
Reference: Eaton JE, Vesterhus M, McCauley BM,
Atkinson EJ , Schlicht EM, Juran BD, Gossard AA, LaRusso NF, Gores GJ, Karlsen TH, Lazaridis KN.
Primary Sclerosing Cholangitis Risk Estimate Tool (PREsTo) Predicts Outcomes in PSC: A Derivation & Validation Study Using Machine Learning. Hepatology. 2018 May 9 Epub 2018 May 09 PeerReviewArticle
Pub Med ,
Doi
DISCLAIMER: The content on the site is NOT medical advice. Although some content may be provided by medical professionals,users acknowledge that access or use of the content does not create a provider-patient relationship and does not constitute medicaladvice, treatment, diagnosis or services of any kind. The information is provided for educational purposes only and as such is nota substitute for professional medical attention and treatment by medical professionals. Users are solely responsible and accept allliability resulting from use of the content and any related services or products.
App Maintainer: Bryan McCauley (mccauley.bryan@mayo.edu)